series-a
Stage
1
Investors
About
Latigo Biotherapeutics is a biopharmaceutical company focused on developing novel immunotherapies for cancer and infectious diseases using next-generation antibody technologies.
Explore Latigo Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.